Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
Fabrinet, a leader in advanced optical packaging and precision manufacturing services, announced that its management will present at the upcoming J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston. The presentation is scheduled for May 18, 2026, and will be webcast live. Fabrinet operates globally with engineering and…
Global Ship Lease, Inc., a NYSE-listed containership owner and lessor, announced a quarterly dividend declaration of $0.625 per Class A common share for Q1 2026, payable on June 3, 2026. The company operates a diversified fleet of 71 vessels with long-term charters valued at over $2 billion, signaling stable cash flows and a strong market position.
Plains All American Pipeline and its general partner, Plains GP Holdings, announced the appointment of Cynthia B. Taylor as an independent board member of PAA GP Holdings LLC. Taylor, with over 30 years experience in the energy sector including leadership at Oil States International and board roles at AT&T and the Federal Reserve Bank of Dallas, wi…
NextHome, a subsidiary of eXp World Holdings (NASDAQ: AGNT), announced the launch of two new Southern California offices, NextHome Coastal Estates and NextHome Central Coast, led by experienced brokerage leader Albert Meggers. These new offices, starting with nearly 200 agents, leverage NextHome's new large-office franchise model designed to give o…
Pharvaris N.V., a late-stage biopharmaceutical firm focused on developing oral bradykinin B2 receptor antagonists for hereditary and acquired angioedema, successfully closed an underwritten offering raising $132.3 million. The funds will support ongoing Phase 3 clinical trials and marketing authorization applications for their lead candidates, adva…
CG Oncology, Inc. will present first results from its CORE-008 Phase 2 trial assessing intravesical combination therapy for high-risk BCG-exposed and BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) at the American Urological Association (AUA) 2026 Annual Meeting. The company will also showcase research supported by its NMIBC research fe…
Lifetime Brands, a global designer and marketer of branded consumer home products, announced its participation in the LD Micro Invitational XVI Conference scheduled for May 17-19, 2026, in Los Angeles. CEO Robert Kay and Senior VP of Finance Scott Rabinowitz will hold one-on-one investor meetings during the event.
Allied Gaming & Entertainment Inc. announced a proposal for stockholders to approve a reverse stock split ranging from 1-for-2 to 1-for-25, aiming to optimize its capital structure and support potential future mergers, acquisitions, and financing initiatives. The company is responding proactively to a Nasdaq notice regarding minimum bid price requi…
Chicago Atlantic BDC, Inc., a NASDAQ-listed specialty finance business development company, announced it has filed a shelf registration statement with the SEC to issue up to $500 million of securities, providing greater flexibility to access capital markets and accelerate portfolio expansion. Proceeds may be used for investing, debt repayment, and …
Catalyst Pharmaceuticals announced its financial results for Q1 2026, highlighting a 5.6% year-over-year increase in total product revenue to $149.3 million, driven by strong sales growth of their key promoted products FIRDAPSE® and AGAMREE®. Net income rose to $63.7 million GAAP and $100.3 million non-GAAP, reflecting improved operating performanc…
Columbia Financial, Inc. announced the commencement of its second-step conversion offering of up to 192.6 million common shares to convert from a mutual holding company to a stock holding company. The company has received all necessary regulatory approvals and conditional approval to acquire Northfield Bancorp, Inc., which will close immediately fo…
SI-BONE, Inc. announced its financial results for the first quarter of 2026, revealing an 11.2% worldwide revenue growth to $52.6 million and an improved net loss of $4.3 million. The company also raised its 2026 revenue guidance to between $230 million and $233 million, reflecting confidence in continuing growth driven by expanded product adoption…
Victoria’s Secret & Co. filed a supplement to its proxy statement and issued a letter to shareholders addressing a proxy contest launched by BBRC International and its Chairman Brett Blundy, opposing the re-election of two Board members. The Company highlights its strong operational and financial performance under CEO Hillary Super, including a 152…
Getty Images announced its first quarter 2026 financial results with a modest 1.1% revenue increase and a significant reduction in net loss compared to last year. Despite challenges in segments like Agency and microstock, the corporate subscription business grew, and the company maintained its full-year revenue and adjusted EBITDA guidance. The ong…
Perspective Therapeutics reported Q1 2026 financial results showing increased cash reserves to $271 million following a successful equity offering and detailed progress across its three clinical-stage oncology programs targeting neuroendocrine tumors, melanoma, and FAP-positive solid tumors with multiple clinical catalysts expected throughout 2026.…
Oculis Holding AG reported strong Q1 2026 results highlighting significant progress across its late-stage ophthalmology pipeline. The company completed last patient visit in its pivotal Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema with topline data expected in June 2026, planning NDA submission by year-end. Its genotype-driven Licami…
Health Catalyst, a healthcare intelligence company, reported Q1 2026 financial results showing total revenue of $70.8 million, down 11% year-over-year, with adjusted EBITDA of $9.1 million, up 46%. The company undertook a strategic reset focusing on its technology opportunities, resulting in a significant goodwill impairment charge of $95.5 million…
MARA Holdings, Inc. announced its preliminary, unaudited financial results for the first quarter of 2026 and invited investors to a webcast and conference call to discuss the results. The company continues to focus on deploying digital energy technologies to optimize energy systems and reduce energy demands in computing applications.
Roivant Sciences Ltd. announced it will report financial results for Q4 and fiscal year ended March 31, 2026, and provide an update on its biopharmaceutical pipeline on May 20, 2026. The company develops various drug candidates and utilizes nimble subsidiaries to advance their pipeline, aiming to improve patient outcomes.
Immunovant, a clinical-stage immunology company focused on autoimmune diseases, announced it will report its financial results for the fourth quarter and fiscal year ended March 31, 2026, via a webcast and conference call on May 20, 2026. The company will also provide a business update during the call.
Rigetti Computing announced its financial results for Q1 2026, highlighting revenue growth driven by new quantum system sales and technology milestones. The company launched its 108-qubit Cepheus-1-108Q system, expanded international presence, and confirmed strong cash reserves and no debt position to support ongoing R&D and commercial opportunitie…
Medallion Bank has entered into a multi-year strategic partnership with fintech firm Together Loans to expand consumer loan offerings based on cosigner trust rather than credit scores. This marks the Bank's fifth fintech alliance, contributing to a substantial increase in loan originations through strategic partnerships from $203.6 million in 2024 …
Elicio Therapeutics announced its first quarter 2026 financial results, highlighting a net loss of $11.8 million and cash runway expected to extend into Q4 2026 following recent fundraising efforts. The company provided updates on its Phase 2 AMPLIFY-7P study evaluating ELI-002 7P, an immunotherapy targeting KRAS-driven pancreatic ductal adenocarci…
Nasdaq published its end-of-month short interest data as of April 30, 2026, showing a slight increase in short interest shares and days of average volume across its Global Market and Capital Market securities compared to the prior reporting period. Total short interest across all Nasdaq securities rose moderately, indicating stable but marginally h…
CVRx, Inc. reported a 20% increase in total revenue for Q1 2026 to $14.8 million, driven by a 22% growth in U.S. revenue attributed to expanded sales territories and increased awareness of its Barostim device. The company initiated the BENEFIT-HF clinical trial with the first site activated and patient enrolled in Q2 2026. CVRx maintained its 2026 …
